Phase 2 biotech developing therapies for rare cardiopulmonary diseases.
Industry: Health Care
First Day Return: 0.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/21/2018 |
Offer Price | $5.00 |
Price Range $12.00 - $14.00 | |
Offer Shares (mm) | 9.2 |
Deal Size ($mm) | $46 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/17/2018 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $46 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Malvern, PA, United States |
Founded | 2002 |
Employees at IPO | 18 |
Website www.phasebio.com |